1. Home
  2. INNV vs PHAR Comparison

INNV vs PHAR Comparison

Compare INNV & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InnovAge Holding Corp.

INNV

InnovAge Holding Corp.

HOLD

Current Price

$11.88

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.42

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INNV
PHAR
Founded
2007
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
INNV
PHAR
Price
$11.88
$13.42
Analyst Decision
Sell
Strong Buy
Analyst Count
1
3
Target Price
$7.00
$38.33
AVG Volume (30 Days)
432.0K
5.1K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$853,699,000.00
N/A
Revenue This Year
$12.85
$10.04
Revenue Next Year
$8.88
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
11.76
N/A
52 Week Low
$3.13
$9.54
52 Week High
$12.64
$21.34

Technical Indicators

Market Signals
Indicator
INNV
PHAR
Relative Strength Index (RSI) 69.14 42.81
Support Level $7.33 $12.88
Resistance Level $12.64 $13.61
Average True Range (ATR) 0.75 0.50
MACD -0.07 -0.05
Stochastic Oscillator 66.67 4.47

Price Performance

Historical Comparison
INNV
PHAR

About INNV InnovAge Holding Corp.

InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: